MedEquities Realty Trust (MRT) Stock Rating Lowered by Zacks Investment Research

MedEquities Realty Trust (NYSE:MRT) was downgraded by Zacks Investment Research from a “hold” rating to a “sell” rating in a research note issued on Friday.

According to Zacks, “MedEquities Realty Trust, Inc. owns, develops, operates, leases and disposes healthcare properties and portfolios. It operates primarily in Texas, California, Nevada and South Carolina. MedEquities Realty Trust, Inc. is based in Nashville, Tennessee. “

MRT has been the subject of a number of other research reports. B. Riley set a $12.00 target price on shares of MedEquities Realty Trust and gave the company a “buy” rating in a research note on Thursday, August 9th. ValuEngine cut shares of MedEquities Realty Trust from a “sell” rating to a “strong sell” rating in a research note on Friday, September 14th. Raymond James cut their target price on shares of MedEquities Realty Trust from $12.00 to $10.00 and set a “buy” rating for the company in a research note on Tuesday. Cantor Fitzgerald reiterated a “neutral” rating and issued a $10.00 target price (down previously from $12.00) on shares of MedEquities Realty Trust in a research note on Friday, September 28th. Finally, Canaccord Genuity cut their target price on shares of MedEquities Realty Trust from $13.00 to $12.00 and set an “overweight” rating for the company in a research note on Thursday, August 9th. Two equities research analysts have rated the stock with a sell rating, four have assigned a hold rating and four have issued a buy rating to the company’s stock. The stock currently has an average rating of “Hold” and an average price target of $11.00.

NYSE:MRT opened at $7.18 on Friday. MedEquities Realty Trust has a 1 year low of $6.99 and a 1 year high of $12.00. The company has a market capitalization of $224.63 million, a PE ratio of 6.30 and a beta of 0.65.

MedEquities Realty Trust (NYSE:MRT) last posted its earnings results on Monday, November 12th. The financial services provider reported ($0.07) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.18 by ($0.25). MedEquities Realty Trust had a net margin of 19.98% and a return on equity of 3.39%. The firm had revenue of $9.68 million during the quarter, compared to the consensus estimate of $17.72 million. On average, sell-side analysts forecast that MedEquities Realty Trust will post 1.08 EPS for the current fiscal year.

In other MedEquities Realty Trust news, Director Bluemountain Capital Managemen sold 7,200 shares of MedEquities Realty Trust stock in a transaction on Wednesday, November 21st. The shares were sold at an average price of $7.16, for a total transaction of $51,552.00. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Insiders have sold a total of 365,069 shares of company stock valued at $3,075,050 in the last ninety days. Company insiders own 2.50% of the company’s stock.

A number of institutional investors and hedge funds have recently added to or reduced their stakes in the business. American Century Companies Inc. grew its holdings in MedEquities Realty Trust by 7.1% during the 3rd quarter. American Century Companies Inc. now owns 2,325,880 shares of the financial services provider’s stock worth $22,608,000 after acquiring an additional 153,969 shares during the period. BlackRock Inc. grew its holdings in MedEquities Realty Trust by 14.8% during the 3rd quarter. BlackRock Inc. now owns 1,721,509 shares of the financial services provider’s stock worth $16,733,000 after acquiring an additional 222,015 shares during the period. Renaissance Technologies LLC grew its holdings in MedEquities Realty Trust by 21.5% during the 3rd quarter. Renaissance Technologies LLC now owns 1,020,302 shares of the financial services provider’s stock worth $9,917,000 after acquiring an additional 180,502 shares during the period. Aristotle Capital Boston LLC grew its holdings in MedEquities Realty Trust by 9.4% during the 3rd quarter. Aristotle Capital Boston LLC now owns 1,003,724 shares of the financial services provider’s stock worth $9,756,000 after acquiring an additional 86,324 shares during the period. Finally, Eagle Boston Investment Management Inc. grew its holdings in MedEquities Realty Trust by 3.8% during the 3rd quarter. Eagle Boston Investment Management Inc. now owns 812,689 shares of the financial services provider’s stock worth $7,899,000 after acquiring an additional 29,828 shares during the period. 90.81% of the stock is owned by hedge funds and other institutional investors.

MedEquities Realty Trust Company Profile

MedEquities Realty Trust (NYSE: MRT) is a self-managed and self-administered real estate investment trust that invests in a diversified mix of healthcare properties and healthcare-related real estate debt investments. The Company's management team has extensive industry experience in acquiring, owning, developing, financing, operating, leasing and monetizing many types of healthcare properties and portfolios.

See Also: What are trading strategies for the 52-week high/low?

Get a free copy of the Zacks research report on MedEquities Realty Trust (MRT)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Analyst Recommendations for MedEquities Realty Trust (NYSE:MRT)

Receive News & Ratings for MedEquities Realty Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MedEquities Realty Trust and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply